+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
Healthy Volunteers
ID06366529

Using New Magnetic Resonance Imaging to Non-Invasively Measure Kidney Function and Fibrosis in People With Kidney Problems

Led by Zhen Li · Updated on 2024-04-17

500

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating new magnetic resonance imaging MRI technologies to evaluate renal insufficiency and renal fibrosis, conditions affecting kidney function. These conditions include acute kidney injury AKI and chronic kidney disease CKD, with CKD being a leading cause of death worldwide. Current diagnostic methods like renal biopsy are invasive and limited, so this study explores non-invasive imaging combined with artificial intelligence techniques like radiomics and machine learning to better assess kidney damage and fibrosis. The study collects clinical, imaging, laboratory, and pathological data from patients with renal insufficiency and fibrosis, including those with transplanted kidneys. MRI techniques such as diffusion weighted imaging, arterial spin labeling, blood oxygen level-dependent imaging, magnetic resonance elastography, and magnetization transfer imaging are used to assess kidney function and fibrosis. Image processing software analyzes these images to explore relationships between imaging parameters, body composition, metabolic diseases, and kidney disease severity. Participants will undergo MRI scans and have their clinical and laboratory data collected and analyzed. Researchers track kidney function and fibrosis levels using imaging and laboratory markers like serum creatinine and glomerular filtration rate. The study aims to develop non-invasive methods for diagnosis, treatment evaluation, and prognosis prediction of renal insufficiency and fibrosis, potentially guiding clinical decisions and improving patient outcomes. The primary outcome measure is the time to end-stage kidney disease or death, assessed up to 10 years.

CONDITIONS

Brief Title

Explore New Magnetic Resonance Technology in Assessment of Renal Dysfunction

Research Team

Z

Zhen Li, Doctor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here